1. Home
  2. PBM vs CTHR Comparison

PBM vs CTHR Comparison

Compare PBM & CTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • CTHR
  • Stock Information
  • Founded
  • PBM 1994
  • CTHR 1995
  • Country
  • PBM Canada
  • CTHR United States
  • Employees
  • PBM N/A
  • CTHR N/A
  • Industry
  • PBM
  • CTHR Consumer Specialties
  • Sector
  • PBM
  • CTHR Consumer Discretionary
  • Exchange
  • PBM NYSE
  • CTHR Nasdaq
  • Market Cap
  • PBM 4.0M
  • CTHR 4.1M
  • IPO Year
  • PBM N/A
  • CTHR 1997
  • Fundamental
  • Price
  • PBM $0.05
  • CTHR $1.30
  • Analyst Decision
  • PBM
  • CTHR
  • Analyst Count
  • PBM 0
  • CTHR 0
  • Target Price
  • PBM N/A
  • CTHR N/A
  • AVG Volume (30 Days)
  • PBM 8.8M
  • CTHR 19.6K
  • Earning Date
  • PBM 11-29-2024
  • CTHR 11-26-2024
  • Dividend Yield
  • PBM N/A
  • CTHR N/A
  • EPS Growth
  • PBM N/A
  • CTHR N/A
  • EPS
  • PBM N/A
  • CTHR N/A
  • Revenue
  • PBM N/A
  • CTHR $23,684,860.00
  • Revenue This Year
  • PBM N/A
  • CTHR $31.82
  • Revenue Next Year
  • PBM N/A
  • CTHR N/A
  • P/E Ratio
  • PBM N/A
  • CTHR N/A
  • Revenue Growth
  • PBM N/A
  • CTHR N/A
  • 52 Week Low
  • PBM $0.05
  • CTHR $1.18
  • 52 Week High
  • PBM $14.55
  • CTHR $4.90
  • Technical
  • Relative Strength Index (RSI)
  • PBM 27.59
  • CTHR 40.56
  • Support Level
  • PBM $0.06
  • CTHR $1.32
  • Resistance Level
  • PBM $0.06
  • CTHR $1.52
  • Average True Range (ATR)
  • PBM 0.01
  • CTHR 0.09
  • MACD
  • PBM 0.00
  • CTHR 0.02
  • Stochastic Oscillator
  • PBM 1.07
  • CTHR 35.56

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About CTHR Charles & Colvard Ltd

Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market. The company sells jewels through two operating segments namely Online Channels segment and Traditional segment. It generates maximum revenue from the Online Channels segment. Online Channels segment which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets.

Share on Social Networks: